Molecular Remission Using Low-Dose Immunotherapy with Minimal Toxicities for Poor Prognosis IGHV—Unmutated Chronic Lymphocytic Leukemia

Overview of attention for article published in Cells, December 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 2 X users

podcasts: 1 podcast

Readers on

mendeley: 15 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,462 followers.

Molecular Remission Using Low-Dose Immunotherapy with Minimal Toxicities for Poor Prognosis IGHV- Unmutated Chronic Lymphocytic Leukemia. by Maharaj D, Srinivasan G, Abreu MM, Ko MW, Jewett A, Gouvea J https://t.co/dGP861GuyV

"#Molecular #Remission Using Low-Dose #Immunotherapy with Minimal #Toxicities for Poor #Prognosis IGHV- Unmutated Chronic #Lymphocytic #Leukemia" from Maharaj et al. @DoctorMaharaj Full text: https://t.co/JOyO4fhnVX

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.